This analysis examines the market position and future outlook for Almirall. The profile encompasses global and US specific company strategy, portfolio and pipeline analysis and assessment of financial performance, with US, rest of world and global forecasts for key drugs to 2010. An interactive forecasting and analysis tool provides continually updated quantitative and qualitative information

• Assess Almirall's strategic options in the face of the increasing presence and experience of large pharmaceutical companies within the Spanish market
• Benchmark Almirall's performance against key players in the ethical pharmaceuticals market
• Understand the drivers of Almirall's forecast decline in sales to 2010